Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Moderate Buy” from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned an average recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $86.67.

ACHC has been the subject of a number of recent research reports. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, November 4th. Barclays cut their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. KeyCorp initiated coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st.

Acadia Healthcare Stock Down 0.7 %

Shares of NASDAQ ACHC opened at $39.83 on Thursday. Acadia Healthcare has a 12-month low of $39.64 and a 12-month high of $87.77. The firm’s 50-day simple moving average is $59.60 and its 200 day simple moving average is $66.10. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market cap of $3.70 billion, a price-to-earnings ratio of 13.06, a price-to-earnings-growth ratio of 1.78 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.91 earnings per share. On average, research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. William Blair Investment Management LLC raised its position in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after purchasing an additional 604,070 shares during the period. Point72 Asset Management L.P. increased its stake in Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Acadia Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after buying an additional 77,509 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Acadia Healthcare by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock valued at $71,467,000 after buying an additional 29,936 shares in the last quarter. Finally, Millennium Management LLC increased its position in shares of Acadia Healthcare by 3,067.8% during the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after acquiring an additional 1,055,894 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.